Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Ensysce Biosciences Receives $14M Multi-Year Grant From NIH For Continued Development Of PF614-MPAR Abuse-Deterrent Opioid With Overdose Protection

Author: Benzinga Newsdesk | August 27, 2024 08:09am

Posted In: ENSC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist